News Detail

Enveric Biosciences prices $5 million Nasdaq at-the-market private placement at $2.25/share

PUBT · 23h ago

Listen to the news

Enveric Biosciences prices $5 million Nasdaq at-the-market private placement at $2.25/share

Enveric Biosciences entered definitive agreements for an at-the-market private placement of 2,222,223 common shares, or pre-funded warrants, priced at USD 2.25 per share.
Gross proceeds expected at about USD 5 million, before fees.
Offering includes Series I warrants, short-term Series J warrants for up to 2,222,223 shares each, exercisable at USD 2 per share.
Warrant exercise could raise up to about USD 8.9 million in additional gross proceeds.
Closing targeted on or about April 17, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604162000BIZWIRE_USPR_____20260416_BW777063) on April 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.